Get started
Author

Guillemette de la Borderie

Observed names: G de la Borderie, G. de la Borderie, Guillemette De La Borderie, Guillemette De la Borderie, de la Borderie, Guillemette
ORCID: 0009-0000-6483-0925
Observed ORCID: 0009-0000-6483-0925
OpenAlex ID: A5024694073
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
2023 · James F Howard, Saskia Bresch, et al. · The Lancet Neurology · 305
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
2024 · James F. Howard, Saskia Bresch, et al. · Therapeutic Advances in Neurological Disorders · 58
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria
2023 · Austin G. Kulasekararaj, Anna-Elina Lehtinen, et al. · Haematologica · 11
PDF
Efficacy and safety of zilucoplan in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the phase III randomized RAISE study
2023 · Kimiaki Utsugisawa, Kazushi Deguchi, et al. · Clinical and Experimental Neuroimmunology · 4
Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis
2024 · Guillemette de la Borderie, Damien Chimits, et al. · Therapeutic Advances in Neurological Disorders · 2
P273 Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis
2023 · C. Farmakidis, M. Leite, et al. · Neuromuscular Disorders · 2
Putting Patient Voices at the Heart of Healthcare Decisions: The UNIFIED Public-Private Project
2026 · Esther W. de Bekker-Grob, Jorien Veldwijk, et al. · Patient · 1
PDF
Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis (P1-5.006)
2023 · Michael D. Weiss, Saskia Bresch, et al. · Neurology · 1
RECaST-Surv: A Calibrated Borrowing Method for Survival Endpoints in Unequal Randomized Trials
2026 · Bi, Dehua, Shen, Arlina, et al. · arXiv (Cornell University)
PDF
P.054 Long-term safety and efficacy of zilucoplan in myasthenia gravis: additional interim analyses of RAISE-XT
2024 · A Genge, JF Howard, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Long-term Safety and Efficacy of Zilucoplan in Myasthenia Gravis: Additional Interim Analyses of RAISE-XT (S15.002)
2024 · James F. Howard, Miriam Freimer, et al. · Neurology
Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis
2023 · Angela Genge, M. Isabel Leite, et al. · Journal of the Neurological Sciences
Score fluctuation might be associated with a higher placebo rate in the RAISE trial – Authors' reply
2023 · James F Howard, Babak Boroojerdi, et al. · The Lancet Neurology
2603 Safety and tolerability of zilucoplan in RAISE-XT: a multicenter, open-label extension study in patients with myasthenia gravis
2023 · Angela Genge, Yessar Hussain, et al. · BMJ Neurology Open
PDF
Works count: 16
Citation count: 384
H-index: 4
I10-index: 3
Year
Topic
Type